About Triastek
Triastek is a company based in Nanjing (China) founded in 2015 by Xiaoling Li and Senping Cheng.. Triastek has raised $102.3 million across 4 funding rounds from investors including Zheng Xiaodong, Goldmine and Shanghai Guoxin Investment Development. Triastek operates in a competitive market with competitors including Nuclera Nucleics, CELLINK, Collplant, ROKIT Healthcare and Precise Bio, among others.
- Headquarter Nanjing, China
- Founders Xiaoling Li, Senping Cheng
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$102.3 M (USD)
in 4 rounds
-
Latest Funding Round
$20.4 M (USD), Series B
Sep 28, 2023
-
Investors
Goldmine
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Triastek
Triastek has successfully raised a total of $102.3M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $20.4 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $20.4M
-
First Round
First Round
(01 Jun 2018)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series B - Triastek | Valuation | Shanghai Guoxin Investment Development | |
| Jun, 2021 | Amount | Series B - Triastek | Valuation | Matrix Partners China , CPE | |
| Dec, 2020 | Amount | Series A - Triastek | Valuation | Dalton Venture |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Triastek
Triastek has secured backing from 13 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Zheng Xiaodong, Goldmine and Shanghai Guoxin Investment Development. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Acquisitions are targeted by CPE as a private equity firm.
|
Founded Year | Domain | Location | |
|
Medical industry focused VC firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Triastek
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Triastek
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Triastek Comparisons
Competitors of Triastek
Triastek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, CELLINK, Collplant, ROKIT Healthcare and Precise Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
4D bio-printer solutions for tissue regeneration are provided.
|
|
| domain | founded_year | HQ Location |
Developer of integrated 3D printing and tissue-engineering platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Triastek
Frequently Asked Questions about Triastek
When was Triastek founded?
Triastek was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Triastek located?
Triastek is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Who is the current CEO of Triastek?
Senping Cheng is the current CEO of Triastek. They have also founded this company.
Is Triastek a funded company?
Triastek is a funded company, having raised a total of $102.3M across 4 funding rounds to date. The company's 1st funding round was a Series A of $15.28M, raised on Jun 01, 2018.
What does Triastek do?
Triastek was founded in 2015 and is headquartered in Nanjing, China. Operations center on the pharmaceutical sector, where a 3D printing technology platform is provided for drug design. Development of 3D bioprinters and Melt Extrusion Deposition (MED) technology is emphasized for dosage form creation. Digital pharmaceutical product development is also supported through these innovations.
Who are the top competitors of Triastek?
Triastek's top competitors include Nuclera Nucleics, Allevi and Collplant.
Who are Triastek's investors?
Triastek has 13 investors. Key investors include Zheng Xiaodong, Goldmine, Shanghai Guoxin Investment Development, Matrix Partners China, and CPE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.